DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Azelnidipine
Azelnidipine
Calcium Channel Blocker As a Drug Candidate for the Treatment of Generalised Epilepsies
Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr
A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache
Medicine for Prevention of and Treatment for Arteriosclerosis and Hypertension
Original Article the Effects of Azelnidipine and Amlodipine in Treatment of Mild to Moderate Hypertension: a Systematic Review
Jp Xvii the Japanese Pharmacopoeia
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Download PDF (279K)
Pharmaceutical Appendix to the Harmonized Tariff Schedule
Drug Delivery System for Use in the Treatment Or Diagnosis of Neurological Disorders
WO 2014/127475 Al 28 August 2014 (28.08.2014) P O P C T
Pharmaceuticals and Medical Devices Safety Information No
Quantitative Structure-Interaction Relationship Analysis of 1,4-Dihydropyridine Drugs in Concomitant Administration with Grapefruit Juice
Effects of a New Calcium Channel Blocker, Azelnidipine, on Systemic Hemodynamics and Renal Sympathetic Nerve Activity in Spontaneously Hypertensive Rats
Stembook 2018.Pdf
Calcium Channel Blockers for Bipolar Disorder: a Systematic Review And
WHO-EMP-RHT-TSN-2018.1-Eng.Pdf
Top View
Supplement Ii to the Japanese Pharmacopoeia Seventeenth Edition
(12) Patent Application Publication (10) Pub. No.: US 2014/0235570 A1 Hochman (43) Pub
Photodegradation of 1, 4-Dihydropyridine Antihypertensive Drugs: an Updated Review
Identification of Therapeutic Drugs Against COVID-19 Through Computational Investigation on Drug Repurposing and Structural Modification
Calcium Channel Ca2+ Channels;Ca Channels
Computational Prediction of Drug Solubility in Fasted Simulated and Aspirated Human Intestinal Fluid
Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
Pharmaceuticals and Medical Devices Safety Information No
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Effect of Dimethylsulfoxide on Transdermal Patches of Azelnidipine
The Medical Deconfounder: Assessing Treatment Effects With
(12) United States Patent (10) Patent No.: US 7,678,363 B2 Barlow Et Al
1 SUPPLEMENTAL MATERIAL Blood Pressure-Lowering Interventions To
What Kinds of Patients Requires Prophylactic Therapy?
Wo 2007/044693 A2
Harmonized Tariff Schedule of the United States (2006) Annotated for Statistical Reporting Purposes
Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy In
Table S1. Full Ksrepo Results for GSE58477 and GSE63409
Harmonized Tariff Schedule of the United States (2006) (Rev
Therapeutic and Toxic Blood Concentrations of More Than 1100 Drugs and Other Xenobiotics
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Botanical-Drug Interactions: a Scientific Perspective
Supplementary Table 3
Pharmaceuticals and Medical Devices Safety Information No
Deuterated Reference Standards
Electronic Supplementary Information For
Are Vasopressors Useful in Toxin-Induced Cardiogenic Shock?
Pharmaceutical Appendix to the Tariff Schedule 2
Voltage Gated Sodium and Calcium Channel Blockers for the Treatment
API Domestic Insert .Cdr
Adenosine and Lidocaine (AL) As a Vasodilator in Cardiac Procedures and a Storage Solution for Vascular Banking
Annex Ii-2 Agreement Establishing The
C146-E398a.Pdf
Pharmaceuticals Appendix
Azelnidipine Attenuates Cardiovascular and Sympathetic Responses to Air-Jet Stress in Genetically Hypertensive Rats
The Natural Bile Acid Surfactant Sodium Taurocholate (Natc) As A
The Role of Mitochondrial ATP-Sensitive Potassiumchannels
A Comparative Study of the Diffusion of Antihypertensive and Antidepressant Medications in Germany and Japan
Ep002088154a1*
Glenmark Product-List-September-2020
Pharmaceuticals Appendix
Medications Associated with Geriatric Syndrome (MAGS) and Their Prevalence in Older Hospitalized Adults Discharged to Skilled Nursing Facilities
WO 2007/016766 Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
WO 2017/040864 Al 9 March 2017 (09.03.2017) P O P C T
Download Product Insert (PDF)